Responding to an Arnold Ventures-backed opinion piece in the New England Journal of Medicine attacking tax-exempt hospitals and the 340B program, AHA General Counsel and Secretary Melinda Hatton says the authors’ disclosure form speaks volumes. “Specifically, that it is influenced by a shadowy organization with an obvious bias against hospitals. This article should be understood for what it is: just another attempt by a deep-pocketed organization with a biased agenda to attack hospitals.” READ MORE

Related News Articles

Headline
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court…
Headline
Johnson & Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a…
Headline
The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the state's law protecting against…
Headline
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District…
Headline
A Louisiana district court Sept. 30 upheld a state law prohibiting drug companies from denying Louisiana hospitals 340B discounts for drugs dispensed at…